Priya Bahri, PhD

Principal Scientific Officer, Division for Human Medicines, Pharmacovigilance Office
European Medicines Agency

Presentation(s):

• PLEN-2 - Plenary Session: Communicating COVID-19 Pharmacoepidemiological Research to Patients: Why Is It Important? How Can We Do It? what Are the Implications Now and for the Future?

  Tuesday, August 24, 2021
  8:30 AM – 10:00 AM US Eastern Time

• PLEN-2B - REPEAT: Communicating COVID-19 Pharmacoepidemiological Research to Patients: Why Is It Important? How Can We Do It? what Are the Implications Now and for the Future?

  Tuesday, August 24, 2021
  8:00 PM – 9:30 PM US Eastern Time